Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C

por Rogalska-Taranta, Magdalena, Jaroszewicz, Jerzy, Flisiak, Robert
Publicado 2017

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

por Maasoumy, Benjamin, Port, Kerstin, Markova, Antoaneta Angelova, Serrano, Beatriz Calle, Rogalska-Taranta, Magdalena, Sollik, Lisa, Mix, Carola, Kirschner, Janina, Manns, Michael P., Wedemeyer, Heiner, Cornberg, Markus
Publicado 2013

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting

por Wiegand, Steffen B., Heidrich, Benjamin, Susser, Simone, Rogalska-Taranta, Magdalena, Petersen, Jörg, Böker, Klaus H. W., Grigorian, Natalia, Link, Ralph, Naumann, Uwe, John, Christine, Lueth, Stefan, Malfertheiner, Peter, Manns, Michael P., Wedemeyer, Heiner, Sarrazin, Christoph, Cornberg, Markus
Publicado 2015